Endocrinology. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

Author： Beckers N.G.M.  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.15, Iss.1, 2000-01, pp. : 43-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M   Afnan M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles

By Albano C.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1426-1430

Oxford University Press

Access to resources Recommend Favorite

Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization

By Alvarez C.   Cremades N.   Blasco N.   Bernabeu R.  

Human Reproduction, Vol. 12, Iss. 11, 1997-11 ,pp. : 2366-2369

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration

By Friedler S.   Raziel A.   Schachter M.   Strassburger D.   Bukovsky I.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1944-1948

Oxford University Press

Access to resources Recommend Favorite

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

By Lin Y  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 885-888

Oxford University Press

Access to resources Recommend Favorite